Betsi cancer recovery relies on temporary fixes, audit finds

Betsi Cadwaladr University Health Board is relying on temporary measures to improve cancer care without a single costed plan to tackle long-term pressures, Audit Wales has found. The report, published on Wednesday 21 October, says bought-in clinical support and overtime have helped services manage immediate demand but have not produced sustained improvement.

Waiting-time figure describes March

Audit Wales reports that 54% of patients began treatment within 62 days of cancer first being suspected in March 2026, against the national target of 75%. That is a historical snapshot in the report, not a measure of performance this October. Auditors say the board understands problems including staff shortages, testing delays, ageing equipment and limited facilities. But its cancer priorities are spread across several documents, without a consolidated plan showing how staffing, funding and capacity will support lasting progress.

What the health board has promised

The management response published with the report says the chief operating officer will oversee a single costed cancer plan. It is intended to bring existing improvement programmes into one framework with priorities, milestones, accountable leads, resource requirements and measures of success. The response gives the second quarter of 2027-28 as the planned completion date for the plan and its monitoring arrangements. It gives the final quarter of 2026-27 for incorporating cancer demand and capacity forecasts into existing models. These are the board’s commitments, rather than changes independently verified as complete.

Prevention and longer-term capacity

The audit also calls for better workforce and infrastructure planning, more consistent use of data and a clearer approach to prevention and early diagnosis. Access to support that helps patients prepare for treatment varies between sites, and learning from successful work is not used consistently. The board’s published response proposes a prevention, screening and early-diagnosis improvement plan with public health, primary care and community partners. It also promises to review the Cancer Partnership Board’s membership, responsibilities and reporting arrangements.

What the review does and does not show

The report is dated September 2026 and examines planning, prevention, leadership and performance trends. Audit Wales did not assess service quality, clinical governance or patient experience, and did not audit the underlying data. Its findings concern how services are organised and improved; they do not establish the outcome of any individual patient’s care.